✦ LIBER ✦

Etoposide in recurrent childhood Langerhans' cell histiocytosis: An Italian cooperative study

✍ Scribed by Adriana Ceci; Marino de Terlizzi; Roberto Colella; Donato Balducci; Maria Grazia Toma; Maria Grazia Zurlo; Pierantonio Macchia; Antonia Mancini; Paolo Indolfi; Margherita Locurto; Giovanni Calculli; Maria Cristiani; Manuel Castello

Publisher: John Wiley and Sons
Year: 1988
Tongue: English
Weight: 414 KB
Volume: 62
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19881215)62:12<2528::aid-cncr2820621213>3.0.co;2-#

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Risk of secondary leukemia after treatme

Risk of secondary leukemia after treatment with etoposide VP-16) for Langerhans cell histiocytosis in Italian and Austrian-German populations

✍ Riccardo Haupt; Thomas R. Fears; Ansgar Heise; Helmut Gadner; Giuseppe Loiacono; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 49 KB 👁 2 views

To estimate the risk of secondary leukemias after treatment with etoposide (VP-16), we evaluated subjects treated for Langerhans' cell histiocytosis (LCH) according to cooperative protocols in Italy or in Austria, Germany, Holland and Switzerland (AGDS). For each subject, information was collected o

A Phase II study of all-trans-retinoic a

A Phase II study of all-trans-retinoic acid plus cisplatin and etoposide in patients with extensive stage small cell lung carcinoma : An Eastern Cooperative Oncology Group study

✍ Gregory P. Kalemkerian; Michael Jiroutek; David S. Ettinger; John A. Dorighi; Da 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 2 views

The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of the National Cancer Institute.

A randomized Phase II trial of echinomyc

A randomized Phase II trial of echinomycin, trimetrexate, and cisplatin plus etoposide in patients with metastatic nonsmall cell lung carcinoma : An Eastern Cooperative Oncology Group Study (E1587)

✍ Alex Y. Chang; KyungMann Kim; Hélène Boucher; Philip Bonomi; James A. Stewart; D 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB 👁 2 views

## Background: Patients with metastatic nonsmall cell lung carcinoma (nsclc) usually have a poor prognosis. a chemotherapy regimen containing cisplatin is commonly used for symptom palliation. echinomycin is a potent bifunctional intercalator of double-strand dna; trimetrexate is a new derivative o